Association between the molecular pathobiology of essential hypertension and thrombotic diseases.
Edgington
T S
TS
Departments of Immunology and Vascular Biology, The Scripps Research Institute, La Jolla, CA 92037-1092, USA. tse@scripps.edu
D000804:Angiotensin II / Q000494:pharmacology; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D030801:Animals, Genetically Modified; D003327:Coronary Disease / Q000139:chemically induced / Q000378:metabolism / Q000401:mortality; D004195:Disease Models, Animal; D006801:Humans; D006973:Hypertension / Q000473:pathology*; D051379:Mice; D051381:Rats; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D013925:Thromboplastin / Q000187:drug effects / Q000378:metabolism; D013927:Thrombosis / Q000473:pathology*
D057911:Angiotensin Receptor Antagonists; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D000804:Angiotensin II; D013925:Thromboplastin